Anti-DAD1 monoclonal antibody

Pre-made anti-DAD1 monoclonal antibody(mab)-benchmark antibody for ELISA, affinity binding assay, drug discovery and mechanism of action (MOA) research

Target products collectionGo to DAD1/DAD1 products collection >>
(antibodies, antigen, VLP, mRNA, ORF viral vector, etc)


Product information

Catalog No.Product NameSpecies Reactivity
GM-Tg-hg-IP0664-Ab-1/ GM-Tg-hg-IP0664-Ab-2Anti-Human DAD1 monoclonal antibodyHuman
GM-Tg-rg-IP0664-Ab-1/ GM-Tg-rg-IP0664-Ab-2Anti-Rat DAD1 monoclonal antibodyRat
GM-Tg-mg-IP0664-Ab-1/ GM-Tg-mg-IP0664-Ab-2Anti-Mouse DAD1 monoclonal antibodyMouse
GM-Tg-cynog-IP0664-Ab-1/ GM-Tg-cynog-IP0664-Ab-2Anti-Cynomolgus/ Rhesus macaque DAD1 monoclonal antibodyCynomolgus/ Rhesus macaque
GM-Tg-felg-IP0664-Ab-1/ GM-Tg-felg-IP0664-Ab-2Anti-Feline DAD1 monoclonal antibodyFeline
GM-Tg-cang-IP0664-Ab-1/ GM-Tg-cang-IP0664-Ab-2Anti-Canine DAD1 monoclonal antibodyCanine
GM-Tg-bovg-IP0664-Ab-1/ GM-Tg-bovg-IP0664-Ab-2Anti-Bovine DAD1 monoclonal antibodyBovine
GM-Tg-equg-IP0664-Ab-1/ GM-Tg-equg-IP0664-Ab-2Anti-Equine DAD1 monoclonal antibodyEquine

Size: 1mg | 10mg | 100mg



Product Description

Catalog No.GM-Tg-hg-IP0664-Ab-1/ GM-Tg-hg-IP0664-Ab-2; GM-Tg-rg-IP0664-Ab-1/ GM-Tg-rg-IP0664-Ab-2;
GM-Tg-mg-IP0664-Ab-1/ GM-Tg-mg-IP0664-Ab-2; GM-Tg-cynog-IP0664-Ab-1/ GM-Tg-cynog-IP0664-Ab-2;
GM-Tg-felg-IP0664-Ab-1/ GM-Tg-felg-IP0664-Ab-2; GM-Tg-cang-IP0664-Ab-1/ GM-Tg-cang-IP0664-Ab-2;
GM-Tg-bovg-IP0664-Ab-1/ GM-Tg-bovg-IP0664-Ab-2; GM-Tg-equg-IP0664-Ab-1/ GM-Tg-equg-IP0664-Ab-2
Products NameAnti-DAD1 monoclonal antibody
Formatmab
Target NameDAD1
Protein Sub-locationIntrocelluar Protein
Category of antibody
Derivation (species)Mouse
CH1+2+3 Isotype
(Receptor identification)
IgG
Type of Light Chain (VD-LC)N/A
Expression platformMammalian Expression
Bioactivity validationBinding affinity is validated by ELISA with recombinant soluble protein antigen. The potency in neutralizing, inhibiting or blocking of the target protein is not detected.
TagFc
Products descriptionPre-made anti-DAD1 monoclonal antibody(mab) is expressed by mammalian cell line as a benchmark antibody for cell culture, ELISA or other affinity binding assay or functional assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic)
Purity Purity: ≥95% (SDS-PAGE)
Application Biological drug disovery including cell culture, assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic) and mechanism of action (MOA) research.
Formulation & Reconstitution Lyophilized from GM's Protein Stability Buffer2 (PSB2,Confidential Ingredients) or PBS (pH7.4);
For PSB2, reconstituted with 0.9% sodium chloride;
For PBS, reconstituted with ddH2O.
Storage Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles.

Reference




    Data / case study


    Click to get more Data / Case study about the product.



    Associated products


    CategoryCat No.Products Name
    Target AntigenGM-Tg-g-IP0664-Ag-1Recombinant multi-species DAD1/ OST2 protein


    Target information

    Target IDGM-IP0664
    Target NameDAD1
    Gene ID1603,13135,192275,711840,480238,101088756,614538,100053042
    Gene Symbol and SynonymsDAD-1,DAD1,OST2
    Uniprot AccessionP61803,P61805,E2R4X3,Q5E9C2
    Uniprot Entry NameDAD1_HUMAN,DAD1_RAT,DAD1_CANLF,DAD1_BOVIN
    Protein Sub-locationIntrocelluar Protein
    Category
    DiseaseN/A
    Gene EnsemblENSG00000129562
    Target ClassificationN/A

    The target: DAD1, gene name: DAD1, also named as OST2. DAD1, the defender against apoptotic cell death, was initially identified as a negative regulator of programmed cell death in the temperature sensitive tsBN7 cell line.  The DAD1 protein disappeared in temperature-sensitive cells following a shift to the nonpermissive temperature, suggesting that loss of the DAD1 protein triggered apoptosis.  DAD1 is believed to be a tightly associated subunit of oligosaccharyltransferase both in the intact membrane and in the purified enzyme, thus reflecting the essential nature of N-linked glycosylation in eukaryotes. [provided by RefSeq, Jul 2008].



    About Gmab

    GDU
    GDU



    GMab, developed by GeneMedi, constitutes an advanced library of recombinant monoclonal antibodies, each meticulously designed to target specific molecular entities. Leveraging the sophisticated capabilities of GM’s Taurus™ and LIBRA™ platforms, GMab synthesizes antibodies characterized by high binding affinity, exceptional physicochemical stability, and optimal developability profiles.

    Through expression in mammalian cell lines, GMab has been established as a paradigmatic reference antibody. It holds significance in myriad domains of biological drug discovery, encompassing cellular cultivation, innovative assay methodologies, strategic animal model systematization, in-depth pharmacokinetic & pharmacodynamic (PK/PD) modeling, and intricate mechanism of action (MOA) investigations.